CAMP
CAMP4 Therapeutics·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
CAMP fundamentals
CAMP4 Therapeutics (CAMP) released its earnings on Aug 14, 2025: revenue was 1.50M (YoY 0.00%), beat estimates; EPS was -0.62 (YoY +97.62%), beat estimates.
Revenue / YoY
1.50M
0.00%
EPS / YoY
-0.62
+97.62%
Report date
Aug 14, 2025
EPS
Revenue
Revenue & Expenses
CAMP has released its 2025 Q3 earnings report, with revenue of 795.00K, reflecting a YoY change of NaN%, and net profit of -15.10M, showing a YoY change of -11.98%. The Sankey diagram below clearly presents CAMP's revenue sources and cost distribution.
Key Indicators
CAMP4 Therapeutics (CAMP) key financial stats and ratios, covering profitability, financial health, and leverage.
CAMP4 Therapeutics (CAMP)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
CAMP4 Therapeutics (CAMP)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
CAMP4 Therapeutics (CAMP)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does CAMP4 Therapeutics (CAMP) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track CAMP4 Therapeutics (CAMP) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is the market's earnings forecast for CAMP4 Therapeutics next quarter?What factors drove the changes in CAMP4 Therapeutics's revenue and profit?What guidance did CAMP4 Therapeutics's management provide for the next earnings period?What is CAMP4 Therapeutics's latest dividend and current dividend yield?What were the key takeaways from CAMP4 Therapeutics’s earnings call?What is CAMP4 Therapeutics's gross profit margin?Did CAMP4 Therapeutics beat or miss consensus estimates last quarter?What were the key takeaways from CAMP4 Therapeutics's earnings call?
